These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15584114)

  • 1. How low should your cholesterol go? Even lower may be better. For those at highest risk, very low cholesterol levels may help prevent a second heart attack or stroke.
    Health News; 2004 Oct; 10(10):6. PubMed ID: 15584114
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol: low is good. Lower is better. PROVE IT has doctors rethinking how to treat high cholesterol and what's a good target.
    Harv Heart Lett; 2004 May; 14(9):3. PubMed ID: 15153372
    [No Abstract]   [Full Text] [Related]  

  • 3. New LDL goals: even lower?
    Johns Hopkins Med Lett Health After 50; 2004 Jul; 17(5):1-2, 7. PubMed ID: 15233099
    [No Abstract]   [Full Text] [Related]  

  • 4. Clash of the statins? A trial pitting two popular statins against each other helps answer a far more important question: how low should cholesterol go?
    Harv Heart Lett; 2004 Feb; 14(6):5. PubMed ID: 14980886
    [No Abstract]   [Full Text] [Related]  

  • 5. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 6. "Major surprise" in a new study means likely changes in treatment.
    Heart Advis; 2004 May; 7(5):2. PubMed ID: 15195616
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
    Nissen S
    MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive Lipitor therapy reduced heart attack and stroke by one-third in patients with chronic kidney disease.
    Cardiovasc J S Afr; 2007; 18(1):62. PubMed ID: 17393007
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowering of cholesterol. What role is played by the choice of statins?].
    März W
    MMW Fortschr Med; 2004 Sep; 146(35-36):55. PubMed ID: 15540544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stroke, cholesterol and statins--are there new data about stroke prevention?].
    Ferbert A
    Dtsch Med Wochenschr; 2001 Jun; 126(22):664-70. PubMed ID: 11450627
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin effective in preventing recurrent stroke.
    Duke Med Health News; 2006 Nov; 12(11):2. PubMed ID: 17225303
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on heart disease. Evidence mounts for even lower LDL.
    Clark WL
    Diabetes Self Manag; 2007; 24(1):29-30, 32. PubMed ID: 17283507
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract]   [Full Text] [Related]  

  • 17. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.